Erythromelalgia-like eruption in parkinsonian patients treated with bromocriptine.

Published

Journal Article

In a previous report about the chronic use of bromocriptine in Parkinson disease, a distinctive cutaneous eruption was noted and termed "erythromelalgia." This eruption has occurred in 9 of 110 patients on chronic bromocriptine therapy; histopathologic examination in 3 patients showed a prominent perivascular lymphocytic infiltration and perivascular edema of the dermis, without frank vasculitis. This is a reversible unwanted effect of bromocriptine therapy.

Full Text

Duke Authors

Cited Authors

  • Eisler, T; Hall, RP; Kalavar, KA; Calne, DB

Published Date

  • October 1, 1981

Published In

Volume / Issue

  • 31 / 10

Start / End Page

  • 1368 - 1370

PubMed ID

  • 6213882

Pubmed Central ID

  • 6213882

International Standard Serial Number (ISSN)

  • 0028-3878

Digital Object Identifier (DOI)

  • 10.1212/wnl.31.10.1368

Language

  • eng

Conference Location

  • United States